Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Curvebeam AI Ltd. ( (AU:CVB) ) has issued an announcement.
CurveBeam AI will showcase its point-of-care weight-bearing CT imaging systems and AI-driven assessment software at the upcoming NWR Virtual Healthcare Conference, where CEO Greg Brown is scheduled to present on 26 March 2026. The presentation, which will be accessible live online with an on-demand replay, is aimed at engaging shareholders and potential investors, reinforcing the company’s visibility in the healthcare technology sector and potentially broadening interest in its musculoskeletal imaging solutions.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited is a medical technology company that develops, manufactures and sells specialised CT scanners and AI-enabled SaaS clinical assessment tools for musculoskeletal care. Its flagship HiRise device delivers weight-bearing and traditional CT imaging, offering advantages over conventional CT or MRI, with operations based in Melbourne and global headquarters in Hatfield, Pennsylvania.
Average Trading Volume: 836,891
Technical Sentiment Signal: Sell
Current Market Cap: A$27.23M
See more data about CVB stock on TipRanks’ Stock Analysis page.